NCT05167266Completed
Long-Covid: Treatment of Cognitive Difficulties
Immediate and Long Term Cognitive Improvement After Cognitive Versus Emotion Management Psychoeducation Programs: a Randomised Trial in Covid Patients With Neuropsychological Difficulties
Source: ClinicalTrials.gov · Last updated 9 Jul 2024
Brief summary (registry, in English)
The purpose of the study is to explore the potential effectiveness of two common low-dose interventions, one targeting cognitive difficulties and the other targeting affective difficulties on quality of life and cognition in people suffering from long-COVID with cognitive complaints.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 130 (actual)
- First submitted
- 21 Dec 2021
- Start date
- 15 Mar 2022
- Primary completion date
- 26 Jan 2024
- Lead sponsor
- University of Liege
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT05167266
What you commit to
- Study type: Interventional
- Participants enrolled: 130
- From 15 Mar 2022 to the primary completion date, 26 Jan 2024
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any chronic or remote neurological disorder (i.e. stroke, head trauma, epilepsy, tumor);
- Cognitive impairment (minor or major neurocognitive disorder; intellectual disability) preexisting to the Covid-19 episode;
- Acute brain injury or acute encephalopathy from another aetiology than covid (e.g., sepsis, liver or renal failure, alcohol or drug withdrawal, drug toxicity);
- Documented preexisting history of psychiatric illness, including substance abuse; Open-heart cardiac surgery or cardiac arrest during the last 6 months;
Other
- Current hospitalization;
- Current revalidation care with cognitive treatment
Who the study is looking for
- Subjects able to understand the information and consent forms;
- Medically stable and at least 3 months after positive PCR for Covid-19;
- Self-reported sufficiently good physical condition to attend the appointment;
- No major hearing or vision disorders;
- Cognitive complaints that place the person in the top 20% of dissatisfied functioning on the BRIEF or MMQ questionnaires;
- Poor objective performance supported by a score below the 20th percentile on one task of the cognitive battery.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ULB - CHU Erasme Coordinator of this site? Confirm its status | Brussels | Belgium | Unknown status |
| CHR Citadelle Coordinator of this site? Confirm its status | Liège | Belgium | Unknown status |
| ULiège - CPLU Coordinator of this site? Confirm its status | Liège | Belgium | Unknown status |
| ULiège - CHU Coordinator of this site? Confirm its status | Liège | Belgium | Unknown status |
| CHC Mont Légia Coordinator of this site? Confirm its status | Liège | Belgium | Unknown status |
Related publications
- Cognitive and affective psychoeducation for Long COVID: a randomized controlled trial.Brain Commun · 2025 · PMID 41277895
This page is information, not medical advice. Discuss any trial with your doctor.